Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2026-01-13 @ 7:23 AM
Study NCT ID:
NCT06147518
Status:
UNKNOWN
Last Update Posted:
2023-12-08
First Post:
2023-11-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis
Sponsor:
Institute of Liver and Biliary Sciences, India
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ILBS-Cirrhosis-68
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None